Intradiscal administration of autologous platelet‐rich plasma in patients with Modic type 1 associated low back pain: A prospective pilot study

Documenti analoghi

• The role of the complement system in disc degeneration and Modic changes
  di: Irina Heggli, et al.
  Pubblicazione: (2024)
• Pharmacokinetics of PP353, a formulation of linezolid for intervertebral disc administration, in patients with chronic low back pain and Modic change Type 1: A first‐in‐human, Phase 1b, open‐label, single‐dose study
  di: Shiva S. Tripathi, et al.
  Pubblicazione: (2024)
• Modic Change Bone Marrow Neutrophils Are Activated and Degrade Cartilage Endplates
  di: Irina Heggli, et al.
  Pubblicazione: (2026)
• Proteomic analysis of serum in a population‐based cohort did not reveal a biomarker for Modic changes
  di: Friederike Schulze, et al.
  Pubblicazione: (2024)
• Efficacy of using autologous cells with graft substitutes for spinal fusion surgery: A systematic review and meta‐analysis of clinical outcomes and imaging features
  di: F. Salamanna, et al.
  Pubblicazione: (2024)